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ORIGINAL ARTICLE
Feasibility of implementing pulse oximetry screening for
congenital heart disease in a community hospital
EA Bradshaw1, S Cuzzi1,2,3, SC Kiernan2, N Nagel2, JA Becker1,3 and GR Martin1,3
1Children’s National Medical Center, Washington, DC, USA; 2Holy Cross Hospital, Silver Spring, MD, USA and 3The George
Washington University School of Medicine, Washington, DC, USA
Objective: Pulse oximetry has been recognized as a promising screening
tool for critical congenital heart disease (CCHD). The aim of this research
was to study the feasibility of implementation in a community hospital
setting.
Study Design: Meetings were conducted to determine an
implementation plan. Pulse oximetry was performed on the right
hand and foot after 24 h of age. Newborns with a saturation p95% or
a X3% difference were considered to have a positive screen. Screening
barriers, screening time and ability to effectively screen all eligible
newborns were noted.
Result: From January 2009 through May 2010, of 6841 eligible
newborns, 6745 newborns (98.6%) were screened. Of the nine infants
with positive pulse oximetry screens, one had CCHD, four had CHD
and four others were determined to have false positive screens. Average
screening time was 3.5 min (0 to 35 min).
Conclusion: Pulse oximetry can be implemented successfully in
community hospitals without an excessive number of false positives or
additional nursing staff.
Journal of Perinatology (2012) 32, 710–715; doi:10.1038/jp.2011.179;
published online 26 January 2012
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Introduction
Congenital heart disease (CHD) is the most common birth defect
and affects approximately 8 per every 1000 newborns born each
year. Critical CHD (CCHD), severe types of CHD, has an incidence
of approximately 2.5 to 3 per 1000 live births.1 These more serious
defects cause significant morbidity and mortality, accounting for
nearly 40% of deaths in children with congenital anomalies in the
first year of life.2 Over the past two decades numerous advances in
care have resulted in a significant reduction in mortality secondary
to CCHD; however, timely diagnosis remains an issue for these
newborns. Despite prenatal diagnosis and newborn examinations,
as many as 39% of infants diagnosed with CCHD are diagnosed
only after discharge from the newborn nursery.3 Delay in diagnosis
may have significant adverse implications; one study showed
that 43% of cases diagnosed after hospital discharge from
the nursery were in shock at the time of readmission.4
Pulse oximetry has been recommended as a potential newborn
screening test for CCHD. Early efforts provided the conceptual
basis for pulse oximetry in the detection of CCHD.5–9 Subsequent
work has provided additional evaluation of the sensitivity,
specificity and diagnostic gap of pulse oximetry screening.10–14
In 2009, the American Heart Association (AHA) and American
Academy of Pediatrics (AAP) released a statement on the potential
use of pulse oximetry screening to detect CCHD.15 The statement
recognized that the most favorable outcomes are realized when
screening on the right lower extremity is conducted after
24 h of age, using 95% as the cutoff value for additional
consultation and evaluation. The AHA and AAP concluded that
pulse oximetry screening could potentially improve detection
of CCHD. However, universal screening was not endorsed at the
time and the authors recommended that ‘future studies in larger
populations and across a broad range of newborn delivery systems
are needed to determine whether this practice should become
standard of care in the routine assessment of the neonate.’
The primary aims of this research were to determine if pulse
oximetry screening for the detection of CCHD could be successfully
implemented in a large community hospital and to evaluate
the feasibility of implementation (ability to screen all participants,
obstacles encountered during screening and impact on staffing
and/or work flow). A secondary aim of the study was to determine
the number of participants with CCHD identified by suggested
program design.
Methods
A prospective study of implementation was performed at Holy Cross
Hospital (HCH), a large community hospital with approximately
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8500 deliveries per year in Silver Spring, MD, USA. The study period
was from January 2009 through May 2010. The study population
consisted of newborns being admitted to the well baby nursery;
mothers of newborns admitted to the neonatal intensive care unit
(NICU) were not approached for participation. Mothers whose
newborns were eligible for participation were informed about the
study through an educational information sheet (in English and
Spanish) and provided verbal consent if they wished to participate.
The enrolled newborns meeting the following criteria were eligible
for pulse oximetry screening: term or late preterm (X35 weeks
gestation), no prenatal diagnosis of CHD, no dysmorphic features
and no signs of cardiovascular abnormalities, such as cyanosis,
abnormal vital signs or a cardiac murmur. The institutional review
boards (IRB) of Children’s National Medical Center (CNMC) and
HCH approved the study.
Implementation planning
During the development of the research protocol, investigators from
CNMC worked with hospital and nursery leadership from HCH
to determine the best practice for adding pulse oximetry screening
to routine newborn care. Individuals from HCH included the
research team (the nursing director of perinatal services, the
medical director of NICU and the physician pediatric education
director), the Chief Nursing Officer, assistant nurse managers of
the maternity suites, the unit educators and the nursing staff
(registered nurses, licensed practical nurses and certified nursing
assistants) who would be involved in research efforts and screening
of newborns. The final protocol design was formulated through
these collaborative meetings.
Training and education
Prior to the implementation of screening, all members of the
nursing staff practicing in the maternity suites and labor and
delivery were required to attend an educational in-service, lasting
approximately 1 h. Training was conducted over 2 weeks covering
all shifts to ensure that all providers received the training. Each
in-service included education on protocol aims, background and
significance of pulse oximetry screening for CCHD, eligibility
requirements for newborns, study design and methods, potential
risks and benefits, and confidentiality requirements for research
participants. The staff responsible for conducting screening completed
hands-on training on correct pulse oximetry technique, conducted
by a representative from the manufacturer, Masimo Corporation
(Irvine, CA, USA). Completion of a competency checklist and a
knowledge assessment quiz was required for all the nursing staff.
In-service trainings were provided accordingly for newly hired staff
to ensure that 100% of staff was educated. In addition, each member
of the nursing staff, ultrasonographer, licensed independent practi-
tioner (LIP) and physician responsible for providing care in labor
and delivery, newborn nursery, maternity suites and NICU received
a letter of study intent from the investigators.
Implementation of screening
Pulse oximetry screening was performed in conjunction with
newborn metabolic screening. One certified nursing assistant was
assigned to perform metabolic and pulse oximetry screening of
each eligible newborn. When that individual was not scheduled to
work, another nursing staff member was assigned newborn pulse
oximetry screens. Pulse oximetry of the right hand and the right
foot was conducted between 24 h of age and discharge from the
nursery. The Masimo Radical-7 pulse oximeter and a disposable
low noise cable sensor were used to screen each newborn.
Disposable sensors were provided by the study grant and used to
avoid concerns regarding potential for transmission of infection
with reusable probes. To ensure accuracy of the reading obtained,
the individual responsible for screening verified all confidence
indicators, including the signal identification quality and perfusion
index, before reporting saturations. A time requirement for
performing screening on each extremity was not specified, since
confidence indicators were used to indicate readings as accurate.
The individual responsible for screening recorded age (in hours) of
newborn, time that pulse oximetry screening began and ended,
obstacles encountered with equipment, newborn, family or staff
and time spent overcoming obstacles.
If the oxygen saturation was >95% for both the right hand
and the right foot and there was <3% difference between the two,
the test was considered negative and the newborn ‘passed’
screening; no further cardiac evaluation in the well baby nursery
was necessary unless indicated by subsequent physical exam or
clinical condition. If the oxygen saturation was p95% for any
measurement or if there was X3% difference between the two
saturations, the test was considered positive and the newborn was
‘referred’ to his or her physician or LIP. The newborn’s physician
or LIP was informed and responsible for all future decisions
regarding care and evaluation. For newborns who were ‘referred’,
it was recommended that echocardiography be obtained to evaluate
cardiac anatomy and if the oxygen saturation was p90% that
he or she be transferred to the NICU for further monitoring and
evaluation. Decisions regarding echocardiography, additional
consultation or transfer to the NICU were made at the discretion
of the physician or LIP caring for the newborn (Figure 1).
Results
During enrollment, 6860 mothers agreed to have their newborn
participate in the study (Figure 2). Of these, 6841 newborns met
eligibility requirements for screening and 6745 newborns received
full screening (defined as pulse oximetry of both the right hand
and right foot). A total of 19 newborns did not meet eligibility
criteria: 15 demonstrated signs or symptoms of CHD, 3 had
dysmorphic features and 1 newborn was ineligible for reasons not
indicated. No further follow-up of these 19 newborns was obtained
according to the protocol, and therefore it is unknown if they were
Implementing pulse oximetry screening
EA Bradshaw et al
711
Journal of Perinatology
identified to have CCHD. In addition, 96 eligible newborns were
not screened because of staff workload, obstacles faced while
performing screening or early discharge.
The average age at which screening occurred was 42.4 h
(21 to 98 h). The average upper extremity oxygen saturation was
100% (93 to 100%). The average lower extremity oxygen saturation
was 100% (90 to 100%). The average difference between upper and
lower extremity oxygen saturations was 0.2% (0 to 6%). During the
study period, of the 6745 newborns screened, 9 had positive screens
and were referred to their primary physician or LIP for decision
regarding additional testing. Five additional newborns were
incorrectly identified as having negative screens; all of these
newborns had saturations above 95% but had a difference of 3%
between the right hand and right foot; none of these infants had
additional testing or consultation. Of the 9 newborns that were
referred, 6 had additional testing or consultation, including
repeat pulse oximetry (1), echocardiograms (6) and cardiology
consultation (5). Transfer to the NICU was required for two infants,
one with CCHD and one with mirror image dextrocardia and
lobar pneumonia.
Five infants were identified with CHD. One of these infants
had oxygen saturations of 93 and 91%, and was subsequently
diagnosed with CCHD (anomalous drainage of the superior vena
cava to left atrium). Four others were diagnosed with CHD
(dextrocardia, dilated ascending aorta and two atrial septal
defects). One infant with oxygen saturations of 100 and 97% was
found upon further evaluation to have no CHD and was confirmed
as a false positive. Three other infants had referring saturations but
they had no additional testing or consultation ordered. Assuming
that the three infants with positive screens and no additional
workup did not have CHD, there were four referred infants with
false positive results.
Newborn participant eligible* for screening 
Pulse oximetry reading > 95% for both
right hand and right foot and < 3%
difference between the two
Refer – Positive Screen Pass – Negative Screen 
RN caring for participant notified















Pulse oximetry of right hand and right foot performed by Holy
Cross nursing assistant in conjunction with blood-spot newborn screen
Pulse oximetry reading ≤ 95% for right hand
and/or right foot or ≥ 3% difference
between the two
* gestational age ≥ 35 weeks, not diagnosed with CHD in prenatal period, do not have presence of dysmorphic
features, and have not displayed signs of cardiovascular abnormalities such as cyanosis, abnormal vitals signs or
cardiac murmur 
Figure 1 Pulse oximetry screening methods and protocol diagram.
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The average amount of time required for screening was
3.5 min (0 to 35 min). Barriers to performing screening were
identified for a total of 166 of the 6841 enrolled newborns eligible
for screening (2.4%). Barriers were identified in 97 of 6745 infants
who were successfully screened (1.4%) compared with 69 of 96
infants not screened (71.9%). Barriers were identified to be related
to the screening equipment (53.6% of the time) (for example,
‘machine didn’t work’ or ‘difficulty with placement’), staff
(22.9%) (for example, ‘busy day’ or ‘too many metabolic screens’),
infant (19.9%) (for example, ‘infant crying’ or ‘very active’) and
family (3.6%) (for example, ‘mom was in rush’). In 100% of cases
where the barrier was staff-related, the infant was ultimately not
screened. Time required to overcome barriers was documented in
34 infants successfully screened and averaged 5.1 min per infant
(2 to 10 min).
Discussion
Our findings demonstrate that implementation is feasible and
does not result in an excessive number of false positives. It was
particularly important for feasibility to be assessed in a community
hospital, as the vast majority of infants in the United States are
born in such settings. In contrast, most pulse oximetry screening
studies have been performed in research centers that have
access to additional resources.
In August 2011, a national workgroup commissioned by the
United States Health and Human Services (HHS) Secretary’s
Advisory Committee on Heritable Diseases in Newborns and
Children published strategies to implement newborn pulse oximetry
screening.16 The following month, HHS Secretary Kathleen Sebelius
fully endorsed adding screening to the recommended uniform
screening panel and directed national agencies ‘to proceed with
implementation expeditiously’.17 Given these national
endorsements, universal pulse oximetry screening will become
standard of care after the development of needed infrastructure.
Our study supports the feasibility of implementation in a
community hospital setting and evaluates screening ‘in larger
populations and across a broad range of delivery systems’,15 as
requested by the AHA and AAP in 2009.
In our view, implementation feasibility means a high
success rate of screening along with sufficiently low barriers
and resource drain. Successful screening occurred in the large
majority of eligible participants (98.6%). We speculate that
assigning that task to a single certified nursing assistant who
was responsible for the screening whenever she was working
allowed for more consistent and efficient care leading to a high
success rate of screening. Barriers to screening occurred for a
variety of reasons but at a very low frequency (2.4% overall).
Resource equipment utilization includes the pulse oximeter,
which is standard equipment in most hospitals, and the probes
needed to perform screening. Since the research study reported
here, HCH has continued newborn pulse oximetry screening
as standard of care but transitioned to reusable probes to
minimize cost.
6,860 Newborns
6,841 Eligible 19 Ineligible
6,745 Screened 96 Not Screened
6,736 Passed 9  Referred
Assume No Disease No additional orders by PMD
Assume No Disease No additional orders by PMD





Echo;  Cardiology Consult;
Neonatology Consult; NICU
Transfer
PFO Echo; Cardiology Consult
PFO vs Small ASD  Echo; Cardiology Consult
Dilated ascending aorta  Echo; Cardiology Consult
Anomalous drainage of







as “Pass” According to
Screening Protocol
Figure 2 Outcomes of enrolled patients.
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Pulse oximetry screening can be implemented without requiring
additional nursing staff. Existing staff from labor and delivery and
the maternity suites provided education to the providers and
parents and performed all screening protocols. Taking advantage
of staffing models already in place, the program design linked
pulse oximetry screening with newborn metabolic screening so
that a small, consistent group of the nursing staff held primary
responsibility for ensuring that both screenings were completed
before discharge. Pulse oximetry screening time was reported to
be <4 min per newborn on average.
Inclusion of pulse oximetry screening in newborn care did not
necessarily result in a strain on pediatricians, neonatologists
or ultrasonographers due to additional evaluations of failed
screens. During the entire 17-month research period, only 9 of the
6745 newborns screened were referred to their pediatrician for
additional evaluation. In addition, six echocardiograms were
ordered for these newborns with positive pulse oximetry screens.
Historical data shows that 222 echocardiograms were ordered in
the well baby nursery for other indications during that same
time period.
To date, few studies in the United States have evaluated pulse
oximetry screening in non-research settings. Walsh presented data
from a public health initiative in 2007 offering pulse oximetry
screening to all institutions that delivered newborns in Middle
Tennessee. Seventy-seven percent of hospitals agreed to participate,
representing 43% of all births occurring in the region during the
study period. The largest center with 7000 deliveries, among others,
chose not to participate due to concerns about the need for extra
staffing. Of the 14 983 infants offered screening, 97.2% were
successfully screened, almost as high as in our study. Additionally,
0.78% of all infants screened failed testing compared with 0.12% in
our study. Similar to our study, one patient with CCHD was
ultimately identified. Many of the hospitals in the Tennessee study
did not have access to pediatric cardiology services on site
and as such only 2.65% (3 of 113) of failed screens had
echocardiograms performed, compared with our 67% (6 of 9).18
The design and results of our study and Walsh’s differ. We
suspect these differences may be partially explained by education
and training, nursery care delivery systems and available resources.
Walsh’s data came from a public health initiative, without funding
for education and training beyond set-up of the pulse oximeter.
With additional training and defined confidence indicators for
reporting accurate readings, it is not surprising that our screening
took slightly longer on average but resulted in fewer failed screens.
The educational resources developed to train staff and educate
parents during our study have led to the development of an
evidence-based educational toolkit.19 Efforts are currently under
way to evaluate this toolkit in providing aid to nurseries interested
in implementing pulse oximetry screening.
Another major difference lies in HCH’s ability to obtain an
echocardiogram and cardiology consult quickly owing to an
affiliation with a nearby academic center. This led to a very
different approach to pulse oximetry screening and referral
patterns in our institution. We recognize this to be a limitation of
our study in that our results may not be generalizable to nurseries
that do not have echocardiography on site, and further evaluation
would require access to telemedicine or transfer to another
institution. Future studies and public health agencies will need
to address this circumstance to maximize access to care.
After completion of our research and successful implementation
of the newborn pulse oximetry screening program, analysis and
discussion identified a factor not formally studied. Physician and
nursing ‘champions’ for screening were noted to be important
during the implementation process. Two HCH-based physician
investigators were on site, the CNMC-based nursing research
coordinator made intermittent visits, and over time staff nursing
champions were identified due to interest shown. These champions
ensured that screening policy and protocols were carried out
appropriately by serving as advocates for screening, being available
for onsite support and clarification of protocols, encouraging staff
during daily operations, and periodically presenting educational
reinforcement and updated research findings. We speculate that
these champions were instrumental in the success of
implementation.
Regarding our secondary aim, we note that our study
found a low incidence of CCHD identified by pulse oximetry
screening. The true incidence of CCHD in the population
delivered at HCH during the study period could not be determined
due to IRB constraints and enrollment and eligibility requirements.
Because this was a feasibility study, only verbal consent was
obtained, and mothers were informed that contact would not
be initiated following discharge. Consequently, the research
team was unable to determine false negatives for CCHD. However,
the authors of this paper (including a neonatologist at HCH
and two cardiologists at CNMC, the primary referral center for
pediatric cardiology in the region) were unaware of any subsequent
diagnoses of CCHD during the research period. Therefore, it is
probable that there were no false negatives.
The low number of CCHD patients identified among screened
participants can be partially explained by defined research
exclusion criteria causing preselection bias. First, no patients
admitted to the NICU were included in the study; the NICU
population disproportionally includes infants with clinical
presentations frequently associated with CCHD (respiratory distress,
hemodynamic instability or with multiple congenital anomalies).
Second, HCH has a strong maternal fetal medicine program with
active fetal echocardiography that may result in a higher
percentage of CHD diagnosed prenatally than is typical in a
community hospital; all newborns with prenatally diagnosed CHD
met exclusion criteria. Finally, 15 neonates in the well baby
nursery were ineligible to be screened due to specific clinical
concern for CHD; some of these patients may have actually had
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CCHD but we do not know as no follow-up was obtained on these
patients per study protocol.
Conclusions
Newborn pulse oximetry screening for CCHD is feasible and can be
successfully implemented in a community hospital setting with
limited resource drain (including no increase in staffing), few
barriers to screening and a low false-positive rate. Given recent
national endorsements to move forward with universal pulse
oximetry screening, these results are particularly important for
other community hospital settings. Although not formally studied,
subsequent discussions suggest that careful implementation
planning, appropriate education and training, and the support
of stakeholders and champions may be important factors when
implementing similar screening programs elsewhere.
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